- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.84 Å
- Oligo State
- homo-octamer
- Ligands
- 8 x DND: NICOTINIC ACID ADENINE DINUCLEOTIDE(Non-covalent)
- 8 x AMP: ADENOSINE MONOPHOSPHATE(Non-covalent)
AMP.2: 12 residues within 4Å:- Chain A: P.356, L.357, S.358, C.417, Y.418, M.419, R.490, S.516, C.532, A.574
- Ligands: DND.1, POP.3
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:M.419, A:S.516
AMP.11: 13 residues within 4Å:- Chain B: P.356, L.357, S.358, C.417, Y.418, M.419, R.490, S.516, C.532, A.574, L.576
- Ligands: DND.10, POP.12
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:M.419, B:S.516
AMP.19: 12 residues within 4Å:- Chain C: P.356, L.357, S.358, C.417, Y.418, M.419, R.490, S.516, C.532, A.574
- Ligands: DND.18, POP.20
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:M.419, C:S.516
AMP.28: 13 residues within 4Å:- Chain D: P.356, L.357, S.358, C.417, Y.418, M.419, R.490, S.516, C.532, A.574, L.576
- Ligands: DND.27, POP.29
2 PLIP interactions:2 interactions with chain D- Hydrogen bonds: D:M.419, D:S.516
AMP.36: 12 residues within 4Å:- Chain E: P.356, L.357, S.358, C.417, Y.418, M.419, R.490, S.516, C.532, A.574
- Ligands: DND.35, POP.37
2 PLIP interactions:2 interactions with chain E- Hydrogen bonds: E:M.419, E:S.516
AMP.45: 13 residues within 4Å:- Chain F: P.356, L.357, S.358, C.417, Y.418, M.419, R.490, S.516, C.532, A.574, L.576
- Ligands: DND.44, POP.46
2 PLIP interactions:2 interactions with chain F- Hydrogen bonds: F:M.419, F:S.516
AMP.53: 12 residues within 4Å:- Chain G: P.356, L.357, S.358, C.417, Y.418, M.419, R.490, S.516, C.532, A.574
- Ligands: DND.52, POP.54
2 PLIP interactions:2 interactions with chain G- Hydrogen bonds: G:M.419, G:S.516
AMP.62: 13 residues within 4Å:- Chain H: P.356, L.357, S.358, C.417, Y.418, M.419, R.490, S.516, C.532, A.574, L.576
- Ligands: DND.61, POP.63
2 PLIP interactions:2 interactions with chain H- Hydrogen bonds: H:M.419, H:S.516
- 8 x POP: PYROPHOSPHATE 2-(Non-covalent)
POP.3: 9 residues within 4Å:- Chain A: S.358, G.360, V.361, D.362, S.363, K.545
- Ligands: AMP.2, MG.4, CL.9
8 PLIP interactions:8 interactions with chain A- Hydrogen bonds: A:S.358, A:S.358, A:G.360, A:V.361, A:D.362, A:D.362, A:S.363
- Salt bridges: A:K.545
POP.12: 8 residues within 4Å:- Chain B: S.358, G.360, D.362, S.363, K.545
- Ligands: AMP.11, MG.13, CL.17
7 PLIP interactions:7 interactions with chain B- Hydrogen bonds: B:S.358, B:S.358, B:G.360, B:V.361, B:D.362, B:S.363
- Salt bridges: B:K.545
POP.20: 9 residues within 4Å:- Chain C: S.358, G.360, V.361, D.362, S.363, K.545
- Ligands: AMP.19, MG.21, CL.26
8 PLIP interactions:8 interactions with chain C- Hydrogen bonds: C:S.358, C:S.358, C:G.360, C:V.361, C:D.362, C:D.362, C:S.363
- Salt bridges: C:K.545
POP.29: 8 residues within 4Å:- Chain D: S.358, G.360, D.362, S.363, K.545
- Ligands: AMP.28, MG.30, CL.34
7 PLIP interactions:7 interactions with chain D- Hydrogen bonds: D:S.358, D:S.358, D:G.360, D:V.361, D:D.362, D:S.363
- Salt bridges: D:K.545
POP.37: 9 residues within 4Å:- Chain E: S.358, G.360, V.361, D.362, S.363, K.545
- Ligands: AMP.36, MG.38, CL.43
8 PLIP interactions:8 interactions with chain E- Hydrogen bonds: E:S.358, E:S.358, E:G.360, E:V.361, E:D.362, E:D.362, E:S.363
- Salt bridges: E:K.545
POP.46: 8 residues within 4Å:- Chain F: S.358, G.360, D.362, S.363, K.545
- Ligands: AMP.45, MG.47, CL.51
7 PLIP interactions:7 interactions with chain F- Hydrogen bonds: F:S.358, F:S.358, F:G.360, F:V.361, F:D.362, F:S.363
- Salt bridges: F:K.545
POP.54: 9 residues within 4Å:- Chain G: S.358, G.360, V.361, D.362, S.363, K.545
- Ligands: AMP.53, MG.55, CL.60
8 PLIP interactions:8 interactions with chain G- Hydrogen bonds: G:S.358, G:S.358, G:G.360, G:V.361, G:D.362, G:D.362, G:S.363
- Salt bridges: G:K.545
POP.63: 8 residues within 4Å:- Chain H: S.358, G.360, D.362, S.363, K.545
- Ligands: AMP.62, MG.64, CL.68
7 PLIP interactions:7 interactions with chain H- Hydrogen bonds: H:S.358, H:S.358, H:G.360, H:V.361, H:D.362, H:S.363
- Salt bridges: H:K.545
- 8 x MG: MAGNESIUM ION(Non-covalent)
MG.4: 6 residues within 4Å:- Chain A: G.360, V.361, D.362, K.545
- Ligands: POP.3, CL.9
No protein-ligand interaction detected (PLIP)MG.13: 6 residues within 4Å:- Chain B: G.360, V.361, D.362, K.545
- Ligands: POP.12, CL.17
No protein-ligand interaction detected (PLIP)MG.21: 6 residues within 4Å:- Chain C: G.360, V.361, D.362, K.545
- Ligands: POP.20, CL.26
No protein-ligand interaction detected (PLIP)MG.30: 6 residues within 4Å:- Chain D: G.360, V.361, D.362, K.545
- Ligands: POP.29, CL.34
No protein-ligand interaction detected (PLIP)MG.38: 6 residues within 4Å:- Chain E: G.360, V.361, D.362, K.545
- Ligands: POP.37, CL.43
No protein-ligand interaction detected (PLIP)MG.47: 6 residues within 4Å:- Chain F: G.360, V.361, D.362, K.545
- Ligands: POP.46, CL.51
No protein-ligand interaction detected (PLIP)MG.55: 6 residues within 4Å:- Chain G: G.360, V.361, D.362, K.545
- Ligands: POP.54, CL.60
No protein-ligand interaction detected (PLIP)MG.64: 6 residues within 4Å:- Chain H: G.360, V.361, D.362, K.545
- Ligands: POP.63, CL.68
No protein-ligand interaction detected (PLIP)- 36 x CL: CHLORIDE ION(Non-functional Binders)
CL.5: 2 residues within 4Å:- Chain A: P.145, R.146
Ligand excluded by PLIPCL.6: 2 residues within 4Å:- Chain A: R.301
- Chain F: R.94
Ligand excluded by PLIPCL.7: 3 residues within 4Å:- Chain A: R.477
- Chain B: H.508, G.509
Ligand excluded by PLIPCL.8: 5 residues within 4Å:- Chain A: V.361, K.545, R.549, A.572
- Ligands: CL.9
Ligand excluded by PLIPCL.9: 6 residues within 4Å:- Chain A: V.361, K.545, A.572
- Ligands: POP.3, MG.4, CL.8
Ligand excluded by PLIPCL.14: 2 residues within 4Å:- Chain A: G.509
- Chain B: R.477
Ligand excluded by PLIPCL.15: 1 residues within 4Å:- Chain B: S.476
Ligand excluded by PLIPCL.16: 5 residues within 4Å:- Chain B: V.361, K.545, R.549, A.572
- Ligands: CL.17
Ligand excluded by PLIPCL.17: 5 residues within 4Å:- Chain B: V.361, A.572
- Ligands: POP.12, MG.13, CL.16
Ligand excluded by PLIPCL.22: 2 residues within 4Å:- Chain C: P.145, R.146
Ligand excluded by PLIPCL.23: 2 residues within 4Å:- Chain C: R.301
- Chain H: R.94
Ligand excluded by PLIPCL.24: 3 residues within 4Å:- Chain C: R.477
- Chain D: H.508, G.509
Ligand excluded by PLIPCL.25: 5 residues within 4Å:- Chain C: V.361, K.545, R.549, A.572
- Ligands: CL.26
Ligand excluded by PLIPCL.26: 6 residues within 4Å:- Chain C: V.361, K.545, A.572
- Ligands: POP.20, MG.21, CL.25
Ligand excluded by PLIPCL.31: 2 residues within 4Å:- Chain C: G.509
- Chain D: R.477
Ligand excluded by PLIPCL.32: 1 residues within 4Å:- Chain D: S.476
Ligand excluded by PLIPCL.33: 5 residues within 4Å:- Chain D: V.361, K.545, R.549, A.572
- Ligands: CL.34
Ligand excluded by PLIPCL.34: 5 residues within 4Å:- Chain D: V.361, A.572
- Ligands: POP.29, MG.30, CL.33
Ligand excluded by PLIPCL.39: 2 residues within 4Å:- Chain E: P.145, R.146
Ligand excluded by PLIPCL.40: 2 residues within 4Å:- Chain B: R.94
- Chain E: R.301
Ligand excluded by PLIPCL.41: 3 residues within 4Å:- Chain E: R.477
- Chain F: H.508, G.509
Ligand excluded by PLIPCL.42: 5 residues within 4Å:- Chain E: V.361, K.545, R.549, A.572
- Ligands: CL.43
Ligand excluded by PLIPCL.43: 6 residues within 4Å:- Chain E: V.361, K.545, A.572
- Ligands: POP.37, MG.38, CL.42
Ligand excluded by PLIPCL.48: 2 residues within 4Å:- Chain E: G.509
- Chain F: R.477
Ligand excluded by PLIPCL.49: 1 residues within 4Å:- Chain F: S.476
Ligand excluded by PLIPCL.50: 5 residues within 4Å:- Chain F: V.361, K.545, R.549, A.572
- Ligands: CL.51
Ligand excluded by PLIPCL.51: 5 residues within 4Å:- Chain F: V.361, A.572
- Ligands: POP.46, MG.47, CL.50
Ligand excluded by PLIPCL.56: 2 residues within 4Å:- Chain G: P.145, R.146
Ligand excluded by PLIPCL.57: 2 residues within 4Å:- Chain D: R.94
- Chain G: R.301
Ligand excluded by PLIPCL.58: 3 residues within 4Å:- Chain G: R.477
- Chain H: H.508, G.509
Ligand excluded by PLIPCL.59: 5 residues within 4Å:- Chain G: V.361, K.545, R.549, A.572
- Ligands: CL.60
Ligand excluded by PLIPCL.60: 6 residues within 4Å:- Chain G: V.361, K.545, A.572
- Ligands: POP.54, MG.55, CL.59
Ligand excluded by PLIPCL.65: 2 residues within 4Å:- Chain G: G.509
- Chain H: R.477
Ligand excluded by PLIPCL.66: 1 residues within 4Å:- Chain H: S.476
Ligand excluded by PLIPCL.67: 5 residues within 4Å:- Chain H: V.361, K.545, R.549, A.572
- Ligands: CL.68
Ligand excluded by PLIPCL.68: 5 residues within 4Å:- Chain H: V.361, A.572
- Ligands: POP.63, MG.64, CL.67
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Chuenchor, W. et al., Different ways to transport ammonia in human and Mycobacterium tuberculosis NAD+synthetases. Nat Commun (2020)
- Release Date
- 2020-01-08
- Peptides
- Glutamine-dependent NAD(+) synthetase: ABCDEFGH
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
BE
AF
BG
AH
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.84 Å
- Oligo State
- homo-octamer
- Ligands
- 8 x DND: NICOTINIC ACID ADENINE DINUCLEOTIDE(Non-covalent)
- 8 x AMP: ADENOSINE MONOPHOSPHATE(Non-covalent)
- 8 x POP: PYROPHOSPHATE 2-(Non-covalent)
- 8 x MG: MAGNESIUM ION(Non-covalent)
- 36 x CL: CHLORIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Chuenchor, W. et al., Different ways to transport ammonia in human and Mycobacterium tuberculosis NAD+synthetases. Nat Commun (2020)
- Release Date
- 2020-01-08
- Peptides
- Glutamine-dependent NAD(+) synthetase: ABCDEFGH
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
BE
AF
BG
AH
B